Press Release
Artificial Intelligence in Fintech Market Size and Growth Opportunities with COVID19 Impact Analysis
Artificial Intelligence in Fintech Market Size and Forecast 2021-2028 by Verified Market Research specialize in market strategy, market direction, expert opinions, and knowledgeable insight into the global market. The report is a combination of critical information including the competitive landscape; global, regional, and country-specific market size; Market participants; Market growth analysis; Market share; Analysis of opportunities, recent developments, and growth in segmentation. The report also provides other information and thoughtful facts such as historical data, sales, revenue and global market share of Artificial Intelligence in Fintech, product scope, market overview, opportunities, driving force and market share of Artificial Intelligence in Fintech. One of the important factors that make this report interesting is its comprehensive overview of the industry's competitive landscape. The report includes upstream raw materials and downstream needs analyses.
Fetch.ai To Develop AI-Powered Collective Learning Module For Cancer Cell Detection
This partnership will allow PSNC to use and contribute data to train algorithms that can be used by hospitals and research centers worldwide to identify and detect circulating cancer cells in patients' blood or tissue biopsies in the upcoming future. Collective Learning Module, distributed parties can work together to train machine learning models using blockchain technology and AI learning capabilities without sharing the underlying data or trusting any of the individual participants. It was most recently deployed to identify COVID-19 cases using chest X-ray images establishing a clear distinction between COVID-19 versus pneumonia cases. The collective learning protocol successfully distinguished COVID-19 patients from those with pneumonia from different causes with an accuracy of 97%. As a part of this initiative, Fetch.ai's
Enzolytics Announces A Comprehensive Therapeutic Protocol For Production Of Monoclonal Antibodies To Address Ongoing And Future Pandemics
COLLEGE STATION, TX / ACCESSWIRE / June 7, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) has announced a coherent protocol that it intends to execute to meet the Company's objective of producing a therapeutic cure for HIV as well as a planned protocol to address existing and future pandemics. This protocol has been defined as a result of the Company's collaboration with Intel Corporation in the field of applying computer analysis (Artificial Intelligence - A.I.) to accelerate health care discoveries and development. This collaboration includes exploring the interaction of monoclonal antibodies with viruses in 3-dimensional matrices. This opens new innovative pathways for drug discovery and development. The Company is actively exploring biotech partnerships, in the same way the Company is working with Intel Corporation, to advance and provide effective therapies and cures for existing and new viral illnesses. In combination with the Company's patented and clinically tested anti-HIV peptide ITV-1, the Company proposes a collaboration to fully implement the following protocol for developing and deploying therapeutics to address existing and future pandemics.
FICO Launches Executive LinkedIn Live Video Series on Operationalizing Analytics and Artificial Intelligence
Global analytics software provider, FICO, today announced its upcoming executive LinkedIn Live video series, "Coffee with Claus" and "Expect the Unexpected." Hosted by FICO Executive Vice President and Chief Technology Officer, Claus Moldt, "Coffee with Claus" will discuss the role of analytics and artificial intelligence in digital transformation, while "Expect the Unexpected" will feature FICO Chief Analytics Officer Scott Zoldi exploring a range of AI topics, such as ethics, governance, diversity, and regulation, with executive leaders. Many of today's enterprises rely on data, and further AI, to deliver a constant stream of intelligence and insight that can be applied to help them pivot in constantly changing business environments as well as address pressing everyday challenges. "With the COVID-19 pandemic accelerating countless digital transformation journeys, our goal is to ensure enterprises are deploying the data at their disposal in the most beneficial ways, some of which include a need to adopt AI to make robust and informed digital decisions," said Claus Moldt, EVP and CTO at FICO. The first episode of "Coffee with Claus," What is an AI Platform?, airs Tuesday, June 22, 2021 at noon EST and features Forrester Analyst Mike Gualtieri.
AI pioneer, visionary launches autonomous vehicle firm in Toronto - Electronic Products & Technology
Waabi, founded by AI pioneer and visionary Raquel Urtasun, today launched out of stealth to build the next generation of self-driving technology. Waabi's innovative approach unleashes the power of AI to'drive' safely in the real world, bringing the promise of self-driving closer to commercialization than ever before. Waabi also announced today a $83.5-million (USD) Series A financing with backing from best-in-class investors across the technology, logistics and the Canadian innovation ecosystem. The round, which is among the largest Series A rounds ever raised in Canada, was led by Khosla Ventures with additional participation from Uber, Radical Ventures, 8VC, OMERS Ventures, BDC Capital's Women in Technology Venture Fund (WIT), Aurora Innovation Inc., AI luminaries Geoffrey Hinton, Fei-Fei Li, Pieter Abbeel, Sanja Fidler and others. AI and self-driving pioneer Raquel Urtasun is the founder and CEO of Waabi.
Remote-Controlled Robotics Innovator Telexistence Closes $20M Series A-2 Round
WIRE)--Airbus Ventures announces its latest investment in Telexistence, Inc., a leading innovator in remote-controlled robotics with artificial intelligence that has closed a $20M Series A-2 financing round led by a group company of Monoful Inc. and comprising additional funds from KDDI, Deepcore, UTokyo IPC, and multiple new investors. Telexistence has raised about $41 million to date, since the company's inception in 2017. "As we rethink and transform the basic meaning of'existence,' we are actively expanding our in-house engineering team, accelerating product development, and upscaling deployment to the company's growing customer base in offline retail and logistics," explains Jin Tomioka, Telexistence CEO and co-Founder. "This funding signals a new chapter, and we are excited to welcome new partners, still more grateful than ever for Airbus Ventures, our lead Series A investor in 2018, and their mentorship and dedication to our mission." Materializing a vision of a more connected humanity interacting and evolving across multiple spatial and temporal scales, Telexistence releases humans from physical constraints utilizing Telexistence technology, robotics, telecommunication, VR, haptics, and AI.
Senior Engineer, Computer Vision and Machine Learning
The companyOutrider, the pioneer in autonomous yard operations for logistics hubs, helps large enterprises improve safety and increase efficiency. The only company exclusively focused on automating all aspects of yard operations, Outrider eliminates manual tasks that are hazardous and repetitive. Outrider's mission is to drive the rapid adoption of sustainable freight transportation by deploying zero-emission systems. Outrider is a private company backed by NEA, 8VC, and other top-tier investors. For more information, visit www.outrider.ai
Vita Mobile Systems Announces LOI to Acquire an Artificial Intelligence Software Company
IRVINE, CA, June 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Vita Mobile Systems, Inc. (OTC PINK: VMSI), a technology company focused on digital imaging in mobile devices, collection and management of big data and development of artificial intelligence, today announced it has signed a non-binding letter of intent (LOI) to acquire a technology company with proprietary Artificial Intelligence software. The acquisition would see VMSI absorb a company with a proprietary Artificial Intelligence (AI) Resource Engine designed to analyze geolocation-based information and trends to address many of the economic and social concerns the world is facing as it transitions into a new post-pandemic society. "As we emerge from an unprecedented year, we are excited and optimistic for this acquisition and for the future on VMSI. The pandemic reshaped the world, its industries and how people interact and connect. One of the most significant changes the pandemic brought was a revolution in technology used to bring people together virtually. VMSI's products originally had a focus on events where people would come together physically, but the pandemic changed the way people interact and we changed with it. We re-aligned our technology suite to meet the changes and, today, VMSI is well positioned to capitalize on the need for immediate geolocation-based information that has been re-enhanced by the pandemic. During the past months, management has also worked on developing strategic partnerships and evaluating acquisition candidates that would complement our technology foundation," stated Sean Guerrero, CEO of Vita Mobile Systems.
Artificial Intelligence in the Pharmaceutical market worth US$27,156.1 Million in 2031. Visiongain Research Inc.
Visiongain has published a new report on "AI in Pharmaceuticals Market 2021-2031". Embracing Technology to Revolutionize Pharmaceutical Industry There are other fields where the R&D process can be influenced by AI and machine learning. Better approaches to predict chemicals' properties in order to reduce the number of substances that need to be synthesized is obviously an opportunity. This would allow for the consideration of a larger chemical universe and enrich the'chemical palette' open to medicinal chemists. Another field where researchers are starting to use AI and machine learning is mining genomic, proteomic, and metabolic data for improved disease biomarkers and medication efficacy surrogate markers.
Majesco Completes Acquisition of Utilant LLC
MORRISTOWN, N.J.--(BUSINESS WIRE)--Majesco, a global leader of cloud insurance software solutions platforms, today announced that it completed the acquisition of Utilant LLC, a U.S. based InsurTech company providing the industry leading survey management SaaS product suite for Loss Control and Premium Audit surveys and artificial intelligence (AI)/machine learning (ML) data and analytics. Utilant's cutting-edge SaaS solutions, contributory database and AI/ML models deliver the necessary next-generation technology that can address critical insurance trends and help keep pace in today's digital race. This acquisition expands Majesco's extensive product portfolio and adds over 87 customers in the P&C market segment, including global insurance carriers and top risk engineering companies. With this addition, Majesco launches an innovative Data and Analytics business unit combining Utilant technology with Majesco's existing, market-leading data and analytics solution. Utilant Founder and CEO, Patrick Davis joins the Majesco Senior Leadership Team and will lead this new business.